FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387300045> ?p ?o ?g. }

• W4387300045 abstract "Abstract Purpose The aim was to determine whether the real-world first-line progression-free survival (PFS) of patients diagnosed with de novo human epidermal growth factor receptor 2 positive (HER2+) advanced breast cancer (ABC) has improved since the introduction of pertuzumab in 2013. Methods Included were patients systemically treated for de novo HER2 + ABC in ten hospitals in 2008–2017 from the SONABRE Registry (NCT-03577197). First-line PFS in 2013–2017 versus 2008–2012 was determined using multivariable Cox proportional hazards modelling. First-given systemic therapy and the use of locoregional therapy within the first year following diagnosis were determined per period of diagnosis. Results Median and five-year PFS were 26.6 months and 24% in 2013–2017 (n = 85) and 14.5 months and 10% in 2008–2012 (n = 81) (adjusted HR = 0.65, 95%CI:0.45–0.94). Of patients diagnosed in 2013–2017 versus 2008–2012, 85% versus 60% received HER2-targeted therapy and 59% versus 0% pertuzumab-based therapy as first-given therapy. Respectively 27% and 23% of patients underwent locoregional breast surgery, and 6% and 7% surgery of a metastatic site during the first year following diagnosis. Conclusion The prognosis of patients with de novo HER2 + ABC has improved considerably. Since 2013 one in four patients were alive and free from progression on first-given therapy for at least five years." @default.
• W4387300045 created "2023-10-04" @default.
• W4387300045 creator A5004178165 @default.
• W4387300045 creator A5004575257 @default.
• W4387300045 creator A5009689872 @default.
• W4387300045 creator A5018595809 @default.
• W4387300045 creator A5023734176 @default.
• W4387300045 creator A5026641092 @default.
• W4387300045 creator A5027402633 @default.
• W4387300045 creator A5031023319 @default.
• W4387300045 creator A5031537356 @default.
• W4387300045 creator A5034460476 @default.
• W4387300045 creator A5043529041 @default.
• W4387300045 creator A5054754505 @default.
• W4387300045 creator A5056300643 @default.
• W4387300045 creator A5059039439 @default.
• W4387300045 creator A5064077142 @default.
• W4387300045 creator A5065928405 @default.
• W4387300045 creator A5084076657 @default.
• W4387300045 creator A5084940553 @default.
• W4387300045 creator A5092992600 @default.
• W4387300045 date "2023-10-03" @default.
• W4387300045 modified "2023-10-06" @default.
• W4387300045 title "Time trends in real-world treatment patterns and survival in patients diagnosed with de novo HER2+ metastatic breast cancer: an analysis of the SONABRE registry" @default.
• W4387300045 cites W2001683272 @default.
• W4387300045 cites W2005830139 @default.
• W4387300045 cites W2070780645 @default.
• W4387300045 cites W2102032555 @default.
• W4387300045 cites W2120661754 @default.
• W4387300045 cites W2159967578 @default.
• W4387300045 cites W2606329970 @default.
• W4387300045 cites W2800571389 @default.
• W4387300045 cites W2806209829 @default.
• W4387300045 cites W2888034547 @default.
• W4387300045 cites W2900030725 @default.
• W4387300045 cites W2982346646 @default.
• W4387300045 cites W3005643552 @default.
• W4387300045 cites W3007215200 @default.
• W4387300045 cites W3012380787 @default.
• W4387300045 cites W3047914685 @default.
• W4387300045 cites W3128857922 @default.
• W4387300045 cites W3128983896 @default.
• W4387300045 cites W3138028988 @default.
• W4387300045 cites W3158115242 @default.
• W4387300045 cites W3200995907 @default.
• W4387300045 cites W3207557929 @default.
• W4387300045 cites W4206666777 @default.
• W4387300045 doi "https://doi.org/10.21203/rs.3.rs-3316250/v1" @default.
• W4387300045 hasPublicationYear "2023" @default.
• W4387300045 type Work @default.
• W4387300045 citedByCount "0" @default.
• W4387300045 crossrefType "posted-content" @default.
• W4387300045 hasAuthorship W4387300045A5004178165 @default.
• W4387300045 hasAuthorship W4387300045A5004575257 @default.
• W4387300045 hasAuthorship W4387300045A5009689872 @default.
• W4387300045 hasAuthorship W4387300045A5018595809 @default.
• W4387300045 hasAuthorship W4387300045A5023734176 @default.
• W4387300045 hasAuthorship W4387300045A5026641092 @default.
• W4387300045 hasAuthorship W4387300045A5027402633 @default.
• W4387300045 hasAuthorship W4387300045A5031023319 @default.
• W4387300045 hasAuthorship W4387300045A5031537356 @default.
• W4387300045 hasAuthorship W4387300045A5034460476 @default.
• W4387300045 hasAuthorship W4387300045A5043529041 @default.
• W4387300045 hasAuthorship W4387300045A5054754505 @default.
• W4387300045 hasAuthorship W4387300045A5056300643 @default.
• W4387300045 hasAuthorship W4387300045A5059039439 @default.
• W4387300045 hasAuthorship W4387300045A5064077142 @default.
• W4387300045 hasAuthorship W4387300045A5065928405 @default.
• W4387300045 hasAuthorship W4387300045A5084076657 @default.
• W4387300045 hasAuthorship W4387300045A5084940553 @default.
• W4387300045 hasAuthorship W4387300045A5092992600 @default.
• W4387300045 hasBestOaLocation W43873000451 @default.
• W4387300045 hasConcept C121608353 @default.
• W4387300045 hasConcept C126322002 @default.
• W4387300045 hasConcept C143998085 @default.
• W4387300045 hasConcept C185926286 @default.
• W4387300045 hasConcept C2775930923 @default.
• W4387300045 hasConcept C2777329042 @default.
• W4387300045 hasConcept C2779786085 @default.
• W4387300045 hasConcept C2780739268 @default.
• W4387300045 hasConcept C2781164504 @default.
• W4387300045 hasConcept C3019894029 @default.
• W4387300045 hasConcept C50382708 @default.
• W4387300045 hasConcept C530470458 @default.
• W4387300045 hasConcept C71924100 @default.
• W4387300045 hasConceptScore W4387300045C121608353 @default.
• W4387300045 hasConceptScore W4387300045C126322002 @default.
• W4387300045 hasConceptScore W4387300045C143998085 @default.
• W4387300045 hasConceptScore W4387300045C185926286 @default.
• W4387300045 hasConceptScore W4387300045C2775930923 @default.
• W4387300045 hasConceptScore W4387300045C2777329042 @default.
• W4387300045 hasConceptScore W4387300045C2779786085 @default.
• W4387300045 hasConceptScore W4387300045C2780739268 @default.
• W4387300045 hasConceptScore W4387300045C2781164504 @default.
• W4387300045 hasConceptScore W4387300045C3019894029 @default.
• W4387300045 hasConceptScore W4387300045C50382708 @default.
• W4387300045 hasConceptScore W4387300045C530470458 @default.
• W4387300045 hasConceptScore W4387300045C71924100 @default.
• W4387300045 hasLocation W43873000451 @default.
• W4387300045 hasOpenAccess W4387300045 @default.

• next